Zelniker, Thomas A.
Huscher, Dörte
Vonk-Noordegraaf, Anton
Ewert, Ralf
Lange, Tobias J.
Klose, Hans
Dumitrescu, Daniel
Halank, Michael
Held, Matthis
Gall, Henning
Pittrow, David
Hoeper, Marius M.
Frankenstein, Lutz
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (HO 1599/2-1)
German Centre of Lung Research
unrestricted grants from Actelion Pharmaceuticals, Bayer and GSK
Article History
Received: 8 September 2017
Accepted: 22 January 2018
First Online: 24 January 2018
Compliance with ethical standards
:
: Dr. Zelniker has nothing to disclose. Dr. Huscher reports personal fees from Actelion Pharmaceuticals, Switzerland outside the submitted work. AVN reports speakers fees from actelion, and Bayer outside the submitted work. Dr. Ewert has nothing to disclose. Dr. Lange reports other from Compera-Registry, during the conduct of the study; grants, personal fees and non-financial support from Actelion, grants, personal fees and non-financial support from Bayer, grants and personal fees from GlaxoSmithKline, personal fees from Pfizer, personal fees from MSD, grants and personal fees from United Therapeutics, outside the submitted work. Dr. Klose reports grants and personal fees from Actelion, grants and personal fees from GSK, personal fees from Pfizer, grants and personal fees from Bayer, personal fees from MSD, personal fees from United Therapeutics, personal fees from OMT, outside the submitted work. Dr. Dumitrescu reports other from COMPERA-Registry, during the conduct of the study; grants, personal fees and non-financial support from Actelion Pharmaceuticals, personal fees from Bayer, personal fees from GlaxoSmithKline, personal fees from Novartis, personal fees from Servier, outside the submitted work. Dr. Halank reports personal fees and non-financial support from Actelion, personal fees and non-financial support from Bayer, personal fees and non-financial support from GlaxoSmithKline, personal fees from OMT, personal fees from MSD SHARP & DOHME, personal fees from Pfizer, outside the submitted work. Dr. Held reports grants from Actelion, honoraria for lectures from Actelion, Bayer Healthcare, Berlin Chemie, Boehringer Ingelheim, GSK, MSD, Novartis, Pfizer, honoraria for advisory board activities from Actelion, Bayer, Boehringer, GSK, MSD, outside the submitted work and partizipation in clinical trails of Actelion, Bayer, GSK, Pfizer, United Therapeutics. Dr. Gall has nothing to disclose. Dr. Pittrow reports personal fees from Actelion, personal fees from Bayer, personal fees from Pfizer, outside the submitted work. Dr. Hoeper reports personal fees from Actelion, personal fees from Bayer, personal fees from Gilead, personal fees from GSK, personal fees from MSD, personal fees from Pfizer, outside the submitted work. Dr. Frankenstein has nothing to disclose.